Psychedelics Economic Burden Of Major Depressive Disorder Is $326.2 Billion Annually, According To New Study Benjamin A. Smith May 5, 2021 0
PharmaDrug Announces Drug-Repurposing Expert Moshe Rogosnitzky Joins Sairiyo Therapeutics Scientific and Clinical… Mar 9, 2021
World-Renowned Gastric Cancer Expert Dr. Yelena Y. Janjigian Joins Sairiyo Therapeutics Scientific and Clinical… Mar 4, 2021
Mydecine Innovations: Unlocking Fungi’s Pharmacological and Nutraceutical Healing Properties Mar 1, 2021
Revive Therapeutics Provides Update on FDA Phase 3 Clinical Trial for Bucillamine in COVID-19 with Planned Completion… Feb 26, 2021
PharmaDrug Files For FDA Orphan Drug Designation For DMT In Kidney Transplantation and Expands on Its Psychedelics… Feb 25, 2021
Mydecine Announces Exclusive Partnership and Increased Capabilities with Applied Pharmaceutical Innovation (API) Feb 24, 2021
Mountain Valley MD To Include Testing Of South African Mutation In Upcoming COVID-19 BSL-4 Clearance Work Feb 22, 2021
Revive Therapeutics Announces Submission of Investigational New Drug Application with the FDA Jul 1, 2020
